Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
A heart pump device is a device that is utilized for supporting heart function and blood flow in individuals having cardiovascular diseases. This device takes blood from a lower chamber of the heart and injects it to the body and essential organs. This device can also be used in case one or both the ventricles stop working. Essential parts of a heart pump include: a little tube which transfers blood from the heart to a pump; another tube that delivers blood from the pump to our veins, and a power source. The power source is associated with a control unit that observes the pump's capacities. Factors, for example, rising occurrence of cardiovascular diseases, developing geriatric populace having less capability of resisting disease, diminishing number of heart donors, and high predominance of unhealthy lifestyle are the key drivers of the worldwide heart pump devices market.
According to HeartWare International Inc., there are less than 4,000 contributor heart devices accessible worldwide every year. However, high expense of gadgets and implantation strategies and poor repayment situation in developing nations is anticipated to hamper the development of this market amid the conjecture time frame. In developing nations, like, China and India, no scope is accommodated for heart pump devices, hence increasing the expenditure by patients.
The global heart pump devices market is segmented into product type, device type, therapy, end user and geography. Based on product, the market globally is categorised into ventricular assist devices, intra-aortic balloon pumps and total artificial heart. Ventricular assist devices further include left ventricular assist devices, right ventricular assist devices, bi- ventricular assist devices, percutaneous ventricular assist devices and transcutaneous ventricular assist devices. The ventricular assist devices segment is relied upon to develop at the most noteworthy CAGR amid the gauge time frame. High development in the ventricular assist devices market can be principally ascribed to the prolonged trust on these devices for the treatment of heart failure and technological headways to enhance the wellbeing of these devices.
Based on device type, this market is classified into implantable heart pump devices and extracorporeal heart pump devices. The implantable heart pumps fragment is relied upon to grow at the most elevated CAGR amid the forecast period. Technological progressions in implantable heart pump gadgets have made them more dependable and sheltered, in addition have enhanced their proficiency, in this way permitting their long-haul use as a survival alternative for patients who can't experience a heart transplant practice (especially for heart failure patients in the end stage).
By therapy, the global heart pump devices market is segmented into Bridge-To-Candidacy (BTC), Bridge-To-Transplant (BTT), Destination Therapy (DT) and other therapies. The destination therapy section is relied upon to enlist the most elevated CAGR amid the estimate time frame. The selection of DT is probably going to increment in the coming years inferable from mechanical progressions in heart pump technology to enhance their security and viability and the personal satisfaction for patients.
Based on end user, this market is divided into hospitals & clinics, ambulatory surgical centres, research institutes and others. While, geographically, the market is categorised into North America, Europe, Asia Pacific and Rest of the World. Of these, the North American portion is anticipated to represent the biggest share of the market in 2017. The large share of this locale can fundamentally be credited to the rising predominance of cardiovascular illnesses, positive repayment situation, and the expanding number of administrative endorsements. Asia Pacific is relied upon to be the quickest developing business sector amid the gauge time frame, 2020 to 2026. The major players involved in this market are Abbott Laboratories, Abiomed, Medtronic, Getinge, Syncardia Systems, Teleflex, Reliantheart, Terumo, Berlin Heart, Jarvik Heart, Cardiacassist, Fresenius, Medical Care etc.
Why to buy this report:
